Harold J. Burstein, MD, PhD
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Harold J. Burstein, MD, PhD sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,751 sponsors by registered trial count).
Harold J. Burstein, MD, PhD: 5 sponsored US clinical trials, none currently recruiting.
Harold J. Burstein, MD, PhD sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. 0 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 1 trials.
Upper-quartile sponsor footprint
Harold J. Burstein, MD, PhD sits in the upper quartile of the sponsor corpus (#2,411 of 15,751 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer
NCT00670982
Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer
NCT00308178
Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer
NCT00121134
Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer
NCT00146562
Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer
NCT00136539
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
Therapeutic Areas
How the Harold J. Burstein, MD, PhD early-phase archive is shaped
5 indexed studies, none listed as recruiting (0% open); 5 completed (100%).
Phase mix: 0 late (III/IV) vs 3 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.